Ved fortsat langtidsbehandling var 11, 4% af patienterne anfaldsfrie i mindst 6 måneder, og 7, 2% var anfaldsfrie i mindst 1 år.
With continued long-term treatment, 11.4% of the patients were seizure-free for at least 6 months and 7.2% were seizure-free for at least 1 year.